When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Genital tract chlamydia infection

Última revisão: 20 Aug 2025
Última atualização: 01 May 2025

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • presence of risk factors
  • asymptomatic
Detalhes completos

Outros fatores diagnósticos

  • cervical discharge
  • friable cervix
  • abnormal vaginal bleeding
  • penile discharge
  • vaginal discharge
  • dysuria
  • pelvic pain
  • fever/chills
  • nausea/vomiting
  • scrotal pain
  • myalgias
  • abdominal pain
  • mucopurulent rectal discharge or tenesmus
  • joint pain and swelling
  • eye irritation
  • rashes
  • inflammation
Detalhes completos

Fatores de risco

  • age under 25 years, sexually active
  • new sex partner or multiple sex partners
  • sexual activity with infected partner
  • condoms not used
  • history of prior STI
  • ethnicity
  • urban residence and low socio-economic status
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • nucleic acid amplification test (NAAT)
Detalhes completos

Investigações a serem consideradas

  • direct immunofluorescence
  • enzyme immunoassay
  • nucleic acid hybridisation tests
  • cell culture
Detalhes completos

Novos exames

  • rapid and point-of-care tests

Algoritmo de tratamento

AGUDA

confirmed or suspected

Colaboradores

Autores

Matthew M. Hamill, MBChB, PhD, FRCP

Assistant Professor of Medicine

Johns Hopkins University School of Medicine

Baltimore

MD

Declarações

MMH receives royalties for contributing to UpToDate on Lymphogranuloma venereum and for Clinical Care Options. He has an honorarium from Roche Diagnostics for panel STI & HIV 2021 World Congress (virtual) and was a member of the 2021 Roche group on future of POCT for STI. He has also received consulting fees from GSK for the HSV vaccine.

Agradecimentos

Dr Matthew M. Hamill would like to gratefully acknowledge Dr Anne Rompalo and Dr Christopher K. Fairley, the previous contributors to this topic.

Declarações

AR and CKF declare that they have no competing interests.

Revisores

Kenneth Lin, MD

Assistant Editor

American Family Physician

Clinical Assistant Professor

GUSOM Medical Officer

US Preventive Services Task Force

Declarações

KL declares that he has no competing interests.

Lars Jørgen Østergaard, MD, PhD, DMSc

Professor/Head

Department of Infectious Diseases

Aarhus University Hospital

Skejby Sygehus

Aarhus

Denmark

Declarações

LJO has been funded by Pfizer to write a leaflet on Chlamydia infections.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Nwokolo NC, Dragovic B, Patel S, et al. 2015 UK national guideline for the management of infection with Chlamydia trachomatis. Int J STD AIDS. 2016 Mar;27(4):251-67.Texto completo  Resumo

Centers for Disease Control and Prevention. Sexually transmitted infections surveillance, 2023. Nov 2024 [internet publication].Texto completo

Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187.Texto completo  Resumo

US Preventive Services Task Force. Final recommendation statement. Chlamydia and gonorrhea: screening. Sept. 2021 [internet publication].Texto completo

Geisler WM, Uniyal A, Lee JY, et al. Azithromycin versus doxycycline for urogenital chlamydia trachomatis Infection. N Engl J Med. 2015 Dec 24;373(26):2512-21.Texto completo  Resumo

American College of Obstetricians and Gynecologists. Committee opinion no. 737: expedited partner therapy. Jun 2018 [internet publication].Texto completo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Diagnósticos diferenciais

    • Lymphogranuloma venereum
    • Gonorrhoea infection
    • Bacterial vaginosis
    Mais Diagnósticos diferenciais
  • Diretrizes

    • 2025 European guideline on the management of Chlamydia trachomatis infections
    • Reducing sexually transmitted infections
    Mais Diretrizes
  • Folhetos informativos para os pacientes

    Chlamydia

    Mais Folhetos informativos para os pacientes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal